Caliway Biopharmaceuticals Co (ROCO:6919) Days Sales Outstanding : 54.15 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Caliway Biopharmaceuticals Co Days Sales Outstanding?

Caliway Biopharmaceuticals Co's average Accounts Receivable for the six months ended in Dec. 2023 was NT$7.03 Mil. Caliway Biopharmaceuticals Co's Revenue for the six months ended in Dec. 2023 was NT$23.70 Mil. Hence, Caliway Biopharmaceuticals Co's Days Sales Outstanding for the six months ended in Dec. 2023 was 54.15.

The historical rank and industry rank for Caliway Biopharmaceuticals Co's Days Sales Outstanding or its related term are showing as below:

ROCO:6919' s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.63 Med: 75.76 Max: 112.89
Current: 53.71

During the past 5 years, Caliway Biopharmaceuticals Co's highest Days Sales Outstanding was 112.89. The lowest was 51.63. And the median was 75.76.

ROCO:6919's Days Sales Outstanding is ranked better than
65.99% of 882 companies
in the Biotechnology industry
Industry Median: 72.665 vs ROCO:6919: 53.71

Caliway Biopharmaceuticals Co's Days Sales Outstanding increased from Dec. 2022 (44.68) to Dec. 2023 (54.15).

Caliway Biopharmaceuticals Co Days Sales Outstanding Historical Data

The historical data trend for Caliway Biopharmaceuticals Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caliway Biopharmaceuticals Co Days Sales Outstanding Chart

Caliway Biopharmaceuticals Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

62.65

112.89

88.86

51.63

Caliway Biopharmaceuticals Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial			-	-	44.68	55.68	54.15

Competitive Comparison of Caliway Biopharmaceuticals Co's Days Sales Outstanding

For the Biotechnology subindustry, Caliway Biopharmaceuticals Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caliway Biopharmaceuticals Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Caliway Biopharmaceuticals Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Caliway Biopharmaceuticals Co's Days Sales Outstanding falls into.

Caliway Biopharmaceuticals Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Caliway Biopharmaceuticals Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (3.121	+	7.892)	/	2 )	/	38.932	*	365
=	5.5065					/	38.932	*	365
=	51.63

Caliway Biopharmaceuticals Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (6.173	+	7.892)	/	2 )	/	23.701	*	365 / 2
=	7.0325					/	23.701	*	365 / 2
=	54.15

Caliway Biopharmaceuticals Co (ROCO:6919) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Caliway Biopharmaceuticals Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Caliway Biopharmaceuticals Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Caliway Biopharmaceuticals Co (ROCO:6919) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Caliway Biopharmaceuticals Co Ltd (ROCO:6919) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.99, Sec. 1, Xintai 5th Road, 32F.-9, Xizhi District, New Taipei City, TWN, 221

Website

https://www.caliway.com.tw

Caliway Biopharmaceuticals Co Ltd is specialized in the development of new drugs for medical aesthetic and inflammatory diseases. Its leading candidate, CBL-514, is a new drug that can trigger adipocyte apoptosis at the injection site and effectively reduce subcutaneous fat without causing tissue necrosis or prominent side effects.

Caliway Biopharmaceuticals Co (ROCO:6919) Headlines

No Headlines